Elbasvir-Grazoprevir Zepatier
Glecaprevir-Pibrentasvir Mavyret
Ledipasvir-Sofosbuvir Harvoni
Ribavirin Copegus, Rebetol, Ribasphere
Sofosbuvir Sovaldi
Sofosbuvir-Velpatasvir Epclusa
Sofosbuvir-Velpatasvir-Voxilaprevir VoseviSelf-StudyEvaluation and Preparation for Hepatitis C Treatment
Evaluation and Preparation for Hepatitis C Treatment
Sign In or Register to get started
Evaluation and Preparation for Hepatitis C Treatment
You are just a few steps away from free CE credits!
1
Sign in or Register
A free account is required.
2
Study the Material
An entire Cc section, or just a few topics at a time.
3
Take the CE Quiz
5 questions covering the topics in each Cc section.
4
Claim CE Credit
Free CNE and Free CME available!
Section Navigation
Section Navigation
- Lesson 2 Overview
Making a Decision on When to Initiate HCV Therapy - 0%Topic 1
BackgroundActivities - 0%Topic 2
Indications for HCV TreatmentActivities - 0%Topic 3
Contraindications for TreatmentActivities - 0%Topic 4
Treatment ReadinessActivities - 0%Topic 5
Timing of Initiation of TreatmentActivities - 0%Topic 6
Monitoring and Follow-Up if Not TreatedActivities - 0%Topic 7
Summary PointsActivities - Making a Decision on When to Initiate HCV Therapy CE Quiz
Making a Decision on When to Initiate HCV Therapy Overview
About this Lesson
Last Updated: April 1st, 2024
CNE/CME Continuing Education
This lesson qualifies for:
View CE Notices
- 1 CME AMA PRA Category 1 Credit™, or
- 1 CNE contact hour and 1 CE contact hour (does NOT qualify for pharmacology CE for advanced practice nurses)
CNE and CME Origination: September 24th, 2013
CNE and CME Review: April 29th, 2024
CNE and CME Expiration: March 10th, 2027 (4th Edition)
View CE Notices
Steps to Acquire CE for this Lesson:
1
Quiz
Score 80%+
2
Give Feedback
Complete survey
3
Print CE Certificate
Obtain proof of CE4th Edition
This is a substantial revision of the original Lesson. The previous edition was titled Making a Decision on When to Initiate HCV Therapy and available until April 29th, 2024.
Learning Objectives
- Summarize current recommendations for HCV treatment indications in persons with chronic HCV
- List absolute contraindications for HCV treatment with direct-acting antiviral therapy
- Discuss relative contraindications for HCV treatment with direct-acting antiviral therapy
- Describe key patient readiness factors to assess prior to initiating treatment
- Outline general monitoring recommendations when HCV treatment is deferred
Lesson Contributors
Authors
Maria A. Corcorran, MD, MPH
Maria A. Corcorran, MD, MPH
Assistant Professor
Division of Allergy & Infectious Diseases
University of Washington
Assistant Professor
Division of Allergy & Infectious Diseases
University of Washington
Disclosures:
None
Reviewers
David H. Spach, MD
David H. Spach, MD
Professor of Medicine
Division of Allergy & Infectious Diseases
University of Washington
Professor of Medicine
Division of Allergy & Infectious Diseases
University of Washington
Disclosures:
None
Lesson Plan
Quick Reference View
A single document for easy access to every topic in the self-study modules.
PDF version also available.